Friday, July 10, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,798
Companies 1,771
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,798 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 11 of 200 · By data quality, then INN

  1. darunavir

    DARUNAVIR JUNO Janssen-Cilag Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    J05AE10

  2. darvadstrocel

    ALOFISEL Takeda

    EMA: withdrawn

    L04

  3. dasatinib

    DASATINIB ARX Alphapharm Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    L01EA02

  4. daunorubicin

    VYXEOS LIPOSOMAL (PREVIOUSLY VYXEOS) Jazz Pharmaceuticals Ireland Limited

    EMA: approved

    L01XY01

  5. daunorubicin hydrochloride

    DAUNORUBICIN HYDROCHLORIDE Teva Pharma GmbH

    INJECTION FDA: approved

  6. deferasirox

    DEFERASIROX JUNO Novartis Pharmaceuticals

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    V03AC03

  7. defibrotide sodium

    DEFITELIO Jazz Pharmaceuticals Ireland Limited

    INTRAVENOUS FDA: approved

  8. deflazacort

    DEFLAZACORT Amneal Pharma Europe Ltd

    ORAL FDA: approved

  9. demeclocycline hydrochloride

    DECLOMYCIN Amneal Pharma Europe Ltd

    ORAL FDA: approved

  10. dengue tetravalent vaccine (live, attenuated)

    QDENGA Takeda

    EMA: approved

    J07BX04

  11. denileukin diftitox-cxdl

    LYMPHIR Citius Pharmaceuticals

    INJECTION FDA: approved

  12. denosumab

    CORORA Amgen

    SUBCUTANEOUS FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    M05BX04

  13. denosumab-adet

    PONLIMSI Teva Pharma GmbH

    SUBCUTANEOUS FDA: approved

  14. denosumab-mobz

    BONCRESA Amneal Pharma Europe Ltd

    SUBCUTANEOUS FDA: approved

  15. desipramine hydrochloride

    DESIPRAMINE HYDROCHLORIDE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  16. desloratadine

    DESLORATADINE KRKA Teva Pharma GmbH

    ORAL FDA: approved · EMA: approved

    R01BA52

  17. desmopressin acetate

    MINIRIN Regeneron Ireland Designated Activity Company (DAC)

    ORAL FDA: approved

  18. desogestrel

    KIMIDESS Teva Pharma GmbH

    ORAL-21 FDA: approved

  19. desvenlafaxine fumarate

    DESVENLAFAXINE Teva Pharma GmbH

    ORAL FDA: approved

  20. deutetrabenazine

    AUSTEDO Teva Pharma GmbH

    ORAL FDA: approved · EMA: approved

    N07XX16

  21. deutivacaftor

    ALYFTREK Vertex Pharmaceuticals (Australia) Pty.

    ORAL FDA: approved

  22. deutivacaftor / tezacaftor / vanzacaftor

    ALYFTREK Vertex Pharmaceuticals (Australia) Pty.

    EMA: approved

    R07AX33

  23. dexamethasone

    DEXMETHSONE Lacuna Pharma Pty Ltd

    INTRAVITREAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    H02AB02

  24. dexamethasone acetate

    DEXAMETHASONE ACETATE Teva Pharma GmbH

    INJECTION FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,798 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.